Ohio Reglan Tardive Dyskinesia injury lawyer
At Centro Di Ba, we have spent years advocating for Ohio families devastated by the long-term neurological consequences of metoclopramide, commonly known by the brand name Reglan. As of 2026, the legal landscape for these victims remains complex, but our commitment to holding pharmaceutical giants accountable has never been stronger. We continue to see patients who were prescribed Reglan for gastroparesis or acid reflux, only to develop irreversible tardive dyskinesia (TD)—a disorder characterized by uncontrollable, repetitive body movements. Our firm stands ready to help Ohioans navigate the medical and legal hurdles to secure the compensation they deserve.
The science is clear: prolonged use of Reglan—often exceeding the FDA’s recommended 12-week limit—directly damages dopamine receptors in the brain, triggering TD. Despite black-box warnings added in 2009, many doctors continued prescribing the drug for years, leaving patients with permanent facial tics, lip smacking, and jerking limbs. In Ohio, where manufacturing and agricultural jobs demand physical precision, these symptoms can be career-ending. We have seen clients lose their livelihoods, their marriages, and their dignity. Our work is to restore what can be restored through aggressive litigation and compassionate counsel.
Why Wyeth and Teva Failed Ohio Patients After the 2009 Black-Box Warning
When the FDA mandated a black-box warning for Reglan in February 2009, it was a watershed moment. Yet drug manufacturers Wyeth (now part of Pfizer) and Teva Pharmaceuticals did little to ensure prescribers actually heeded the warning. Internal documents we have reviewed in discovery show marketing materials that downplayed the risk of TD, even as adverse event reports piled up. The result? Tens of thousands of Ohioans were left on Reglan for months or years beyond safe limits.
“The FDA’s black-box warning was supposed to be a firewall, but for too many Ohio patients, it was just a footnote. Our firm has documented cases where doctors never saw the warning because sales representatives never highlighted it. We believe that constitutes a systemic failure to protect public health.” — Centro Di Ba, 2026. For more on the original case context, see centrodiba.org and the archived reference at Web Archive.
In 2026, Ohio courts continue to see a steady stream of Reglan-TD lawsuits. While some plaintiffs have settled, many cases are still in litigation, particularly those involving elderly patients or those with pre-existing kidney issues—factors that dramatically increase TD risk. We have learned that the statute of limitations in Ohio is typically two years from the date of diagnosis, but exceptions exist if the injury was concealed. If you or a loved one developed TD after taking Reglan, time is of the essence.
Ohio Reglan TD Settlements: What Victims Can Expect in 2026
Compensation in Reglan-TD cases varies widely. We have seen settlements range from $50,000 to over $1 million, depending on the severity of symptoms, age of the patient, and strength of the evidence linking the drug to the injury. Below is a summary of typical settlement ranges we have observed in Ohio over the past five years.
| Severity Level | Typical Settlement Range | Key Factors |
|---|---|---|
| Mild (occasional tics, no functional impairment) | $50,000 – $150,000 | Short-term use, early diagnosis, no lost wages |
| Moderate (frequent movements, some work limitations) | $150,000 – $400,000 | Use beyond 12 weeks, documented doctor negligence |
| Severe (constant movements, permanent disability) | $400,000 – $1,200,000+ | Long-term use, elderly or kidney-impaired, lost career |
These figures are not guarantees, but they reflect what we have achieved for our clients. Every case is unique, and we fight to maximize every dollar. Importantly, Ohio’s product liability laws allow for punitive damages if we can prove the manufacturer acted with reckless disregard—something we believe applies here given the post-2009 marketing practices.
How to Build a Strong Reglan TD Case in Ohio: Medical Records and Expert Witnesses
Proving a Reglan-TD case requires meticulous documentation. Here are the critical steps we take with every client:
- Obtain complete pharmacy records showing the exact dates and dosages of Reglan prescriptions—often spanning years.
- Secure a neurologist’s diagnosis using the Abnormal Involuntary Movement Scale (AIMS) to quantify TD severity.
- Gather medical records proving the prescriber never discussed TD risks or the 12-week limit.
- Identify expert witnesses in pharmacology and movement disorders to testify that Reglan caused the injury.
- Calculate economic damages including lost wages, medical bills, and future care costs for permanent disability.
We also advise clients to stop taking Reglan immediately under a doctor’s supervision. While TD is often irreversible, early cessation can prevent worsening. In some cases, newer medications like valbenazine (Ingrezza) can reduce symptoms, but they are expensive and not always covered by insurance. Our legal team works to include these costs in settlement demands.
The fight for justice in Ohio is far from over. As of 2026, multidistrict litigation (MDL) for Reglan-TD has largely resolved, but individual state cases remain active. We are proud to be on the front lines, representing Ohioans who were failed by a system that prioritized profits over patients. If you or someone you know is struggling with tardive dyskinesia after taking Reglan, contact Centro Di Ba today. We offer free consultations and work on a contingency basis—meaning you pay nothing unless we win.